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Abstract
Modern DNA sequencing technologies enable geneticists to rapidly identify genetic variation among many human
genomes. However, isolating the minority of variants underlying disease remains an important, yet formidable challenge for
medical genetics. We have developed GEMINI (GEnome MINIng), a flexible software package for exploring all forms of
human genetic variation. Unlike existing tools, GEMINI integrates genetic variation with a diverse and adaptable set of
genome annotations (e.g., dbSNP, ENCODE, UCSC, ClinVar, KEGG) into a unified database to facilitate interpretation and
data exploration. Whereas other methods provide an inflexible set of variant filters or prioritization methods, GEMINI allows
researchers to compose complex queries based on sample genotypes, inheritance patterns, and both pre-installed and
custom genome annotations. GEMINI also provides methods for ad hoc queries and data exploration, a simple
programming interface for custom analyses that leverage the underlying database, and both command line and graphical
tools for common analyses. We demonstrate GEMINI’s utility for exploring variation in personal genomes and family based
genetic studies, and illustrate its ability to scale to studies involving thousands of human samples. GEMINI is designed for
reproducibility and flexibility and our goal is to provide researchers with a standard framework for medical genomics.
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Introduction
Unraveling the genetic components of human disease pheno-
types demands not only accurate methods for discovering genetic
variation, but also reliable strategies for interpreting the relevance
of the identified variants. Owing to evermore accurate DNA
sequencing technologies, human geneticists now have a potent tool
for interrogating nearly every base pair in a human genome.
Similarly, great algorithmic strides have been made [1,2] for
identifying single-nucleotide and insertion-deletion polymorphisms
from the billions of sequenced DNA fragments. However, given
the scale and complexity of these variation catalogs and the
formats that describe them [3], it remains a substantial challenge
to manage and interpret genome-scale variation in the context of a
disease phenotype. While itself limited, we best understand the
consequences of genetic variation affecting protein-coding genes.
Yet as recent studies of loss-of-function variation have shown,
ostensibly damaging variants are frequently artifacts of data,
annotation, or analysis [4,5]. As such, care must be taken in
prioritizing potentially causal variants, even in this seemingly
‘‘simple’’ case. Interpretation is far more challenging in the case of
non-coding variation, as we have only a preliminary grasp of the
functional consequences of non-coding variation on gene regula-
tion and fitness [6,7,8]. Integrating functional genomics annota-
tions from ambitious projects such as ENCODE [9] will thus be
crucial to assessing the impact of non-coding variation.
Given these analytical challenges, systematic efforts to identify
genetic variation underlying disease phenotypes through exome
and genome sequencing clearly depend upon the ability to assess
variants in the context of the incredible wealth of both genomic
and epigenomic annotations that have been curated since the
completion of the human genome. The reality, however, is that
this goal poses both technical and methodological challenges:
genome annotation datasets are often quite large and are
described in myriad file formats. Moreover, they come with
varying documentation, they are frequently modified or updated,
and they are housed in both centralized repositories [10,11] and
on individual laboratory websites. Substantial technical ability is
consequently required for even the most basic exploratory analysis
integrating diverse genome annotations; greater analytic sophisti-
cation requires intricate, lab-specific pipelines that are laborious to
produce and next to impossible to reproduce. We argue that the
human genomics community needs flexible, reproducible, and
scalable software for mining genome variation in the context of
crucial genome annotations.
We have therefore developed GEMINI (GEnome MINIng), a
novel software package that integrates genetic variation in the
VCF format [3] with both automatically installed and researcher-
defined genome annotations into a unified database framework.
By integrating all forms of genetic variation (i.e., SNPs, INDELs,
and structural variants) with diverse genome annotations,
GEMINI allows both biologists and programmers to devise
custom prioritization schemes for both coding and non-coding
variants that meet their research criteria. The GEMINI database
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eliminates the need to develop complex, and often erroneous,
analysis pipelines.
GEMINI provides distinct functionality that is not available
with existing software. Tools such as VEP [12] and snpEff [13]
exclusively predict the consequence of variation on gene
transcripts. Others such as ANNOVAR [14] and our own
BEDTools [15] enable one to filter variants in a VCF file based
on overlaps with individual annotation files (e.g., a BED file of
CpG islands). Integrating the many annotations necessary for
genome-scale analyses in this manner inevitably requires custom
scripts and is therefore laborious and error-prone. Other
researchers have recognized this limitation and developed software
that attempts to automate variant analysis and centralize genome
annotations with genetic variants. However, most extant software
packages are either focused primarily on applying disease
association tests to variants identified among a study cohort (e.g.,
PLINK/SEQ, unpublished), provide a limited set of annotations,
or are more difficult to use because annotations are not directly
integrated with genetic variation [16]. Moreover, few existing tools
allow researchers to explore genetic variation with Structured
Query Language (SQL), a powerful and expressive system for data
analysis. Other web-based tools such as Annotate-it [17] provide a
convenient graphical interface for comparing variants to an
integrated set of genome annotations. Whereas Annotate-it excels
at organizing genome analysis experiments and data visualization,
it has limited functionality for non-coding variation and supports
neither INDELs nor structural variants.
In contrast, as described in the following sections, GEMINI
extends and generalizes these basic data exploration concepts to
allow researchers to: query variants and genome annotations in a
common database framework using SQL, augment the database
with custom annotations, prioritize variants based on sample
genotypes and inheritance patterns, and develop intricate, yet
reproducible analyses, using a standard database framework and
programming interface. As such, GEMINI serves both as a stand-
alone genome analysis toolkit and as a framework upon which to
build sophisticated graphical analysis and visualization tools.
Design and Implementation
Design overview
As outlined in Fig. 1, GEMINI imports genetic variants and all
sample genotypes from a VCF file into a SQLite (http://www.
sqlite.org/) database (Fig. 1A). We prefer the use of a relational
database to alternative, ‘‘NoSQL’’ approaches (e.g., Redis,
MongoDB) because of the expressive power that SQL provides
for constructing data exploration queries, its intuitive syntax, and
its familiarity to many researchers. SQLite was chosen because of
its speed, broad availability, and, in contrast to other database
frameworks, its portability: a given GEMINI database can easily
be shared as a single file among laboratory members and
collaborators without a dedicated database server or additional
configuration. Moreover, this portability allows researchers to
‘‘version’’ their research as samples and/or variant calling
algorithms change by storing GEMINI databases along with the
underlying VCF and sequence alignment files.
Each variant in an input VCF file is extensively annotated
through automatic (via Tabix [18] and pysam [19]) comparisons
to a comprehensive and growing set of genomic annotation files
including: dbSNP [20], ENCODE [6], ClinVar, 1000 Genomes
[21], the Exome Sequencing Project [22], KEGG [23], GERP
scores [24], and HPRD [25] (Fig. 1B; Methods). Annotated
variants are loaded as rows in the variants database table. In
the interest of reproducibility, the database also tracks (via the
resources table) which version of the built-in annotations were
used to create the database. Moreover, researchers may also
augment the built-in annotations with custom annotation files
relevant to their research (Fig. 1C, Fig. 2A). As we discuss in
more detail below, storing extensively annotated variants in a
relational database facilitates sophisticated data exploration via
SQL queries and pre-defined GEMINI ‘‘tools’’ (a complete list
of database tables and annotations are available in Table S1).
By using a database framework, we are able to not only index
variants by their genomic coordinates, but also by their
associated annotations. This expedites more sophisticated
queries such as, ‘‘what are all of the novel variants that overlap CpG
islands and have an alternate allele frequency greater than 5% in my
cohort?’’ Such functionality distinguishes GEMINI from tools such
as Tabix [18] and VCFtools [3] which can either index variants
solely by genomic position, or isolate specific variants by scanning
the entire VCF file (which are often tens or hundreds of gigabytes in
size) for desired values in the VCF format’s INFO field.
Efficient storage of sample genotype information
Studies of human disease require the ability to compare the
genotypes of individual samples (e.g., cases versus controls) for
each observed variant. A straightforward, yet impractical strategy
for representing sample genotype information is to store the
sample genotypes for each variant as distinct rows in a separate
genotypes database table. In this model, accessing all observed
genotypes for a given variant would thus require joining a
variants table to a genotypes table, a strategy that scales very
poorly when representing variation in VCF files with millions of
variants and hundreds to thousands of samples. For example,
merely one million variants for 1000 samples would yield 1 billion
genotype rows and result in extremely poor query performance
and scalability. Recognizing this limitation, we instead represent
genotype information (genotype, phase, depth, etc.) for each
sample as a compressed array that is stored as single column for
each variant row (Fig. 1D). This inherently constrains the number
of rows in the database to the number of variants observed. More-
over, since the proportion of rare variants will increase as a func-
tion of the number of samples, the majority of genotypes for rare
variants will be identical (i.e., homozygous for the major allele) and
thus highly compressible. Therefore this strategy enables both
query performance and scalability while still providing necessary
access to individual sample genotype information.
Parallelization
When VCF files contain genotypes from many samples, simply
reading and parsing the VCF file is time consuming. The
additional cost of variant annotation causes the loading of a
VCF file into GEMINI to be very computationally intensive.
Therefore, in an effort to allow the loading to scale to the size of
current and future VCF files including thousands of samples, the
loading step can be parallelized on single machines with multiple
CPUs. In addition, through use of the IPython.parallel library
(http://ipython.org/ipython-doc/dev/parallel/), loading can be
parallelized with computing clusters supporting LSF, Sun Grid
Engine, or Torque load management systems.
Variant annotations
Discerning the functional relationship between experimentally
identified genetic variants and a phenotype demands placing
variants in the context of the extensive genome annotations that
have been curated since the completion of the human genome.
Exploring Genetic Variation with GEMINI
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directly into the SQLite database including chromosomal cyto-
bands, CpG islands, regions under evolutionary constraint,
RepeatMasker [26] annotations, segmental duplications, known
assembly gaps, ‘‘mappability’’ scores [27], and regional recombi-
nation rates (Fig. 1B).
In addition, several informative variant statistics and population
metrics are calculated for each variant. The rationale behind this is
that the VCF format is designed to store low-level sample genotype
information such as the called genotype, its likelihood, and the
sequencing depth that was observed for the sample. Consequently,
it is often difficult to query VCF files based on summary genotype
metrics such as the count of each genotype ‘‘type’’ (e.g., how many
heterozygotes were observed for this variant?), or the count of samples
lacking a called genotype. In an effort to facilitate downstream
variant analysis, GEMINI derives and stores these and other
metrics such as deviation from Hardy-Weinberg equilibrium,
inbreeding coefficients, and nucleotide diversity estimates.
Annotating coding variation
There are now several software packages [12,13,14] for
predicting the impact of genetic variation on protein coding
transcripts. Rather than reinvent the techniques already present in
these tools, GEMINI currently integrates and standardizes
predictions made by either snpEff or VEP. GEMINI augments
these annotations with the Pfam-A [28] protein domain that the
variant affects. Each variant’s clinical significance is also cataloged
by comparisons to ClinVar (http://www.ncbi.nlm.nih.gov/
clinvar/). Lastly, GEMINI annotates functional pathway and
protein-protein interactions through built-in KEGG and HPRD
catalogs, thereby permitting researchers to explore the mutational
burden in pathways and interacting proteins.
Figure 1. Overview of GEMINI database and annotations. (A) Genetic variants in the VCF format are loaded into the GEMINI database
framework using the load sub-command. A PED file describing the sex, phenotype(s), and relatedness of the samples in the VCF may be provided to
facilitate downstream analyses such as searches for de novo mutations or variants meeting specific inheritance patterns. (B) Each variant in the VCF
file is annotated with information from several genome annotation sources that facilitate variant exploration and prioritization. The variants and
associated annotations are stored in the variants and variant_impacts tables. (C) Researchers may also integrate their own annotations to
facilitate custom analyses using annotations that are not pre-installed with the GEMINI software. (D) Genotype information for all samples is stored as
compressed arrays to enable database scalability and users may access genotype information for individual samples through an enhanced SQL
interface. (*) KEGG and HPRD annotations are not stored directly in the variants table, but are rather used in the context of specific GEMINI analysis
tools.
doi:10.1371/journal.pcbi.1003153.g001
Figure 2. Variant mining and tool development with the GEMINI database framework. (A) Storing variants and annotations in the same
database framework enables ad hoc SQL data exploration through both the query module and a Python programming interface. Analysis queries
can filter variants based on pre-installed annotations (e.g., in_dbsnp=0) and custom annotations (e.g., my_disease_regions=1). Users may
also select and filter variants based upon the genotypes of specific individuals (e.g., gt_types.mom= =HET), thus allowing one to identify variants
meeting specific inheritance patters, as shown here. (B) The GEMINI database framework also enables the development of tools that facilitate
automated analyses for routine analysis tasks. (C) Moreover, it serves as a standard interface for developers to develop new tools and algorithms and
to implement improved statistical tests for population and medical genetics.
doi:10.1371/journal.pcbi.1003153.g002
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Assessing the consequence of non-coding variation remains
challenging, yet new insights are being made by large-scale
endeavors to map human regulatory elements among hundreds of
cell types [6,8]. Nonetheless, attempting to understand non-coding
variation in the context of disease requires the integration of many
diverse genome annotations and exceedingly few tools exist to
facilitate such research. As such, we have integrated three primary
chromatin annotations from the ENCODE project: observed
transcription factor binding sites [29], DNase1 hypersensitivity sites
among 125 cell types [8], and Segway/ChromHMM consensus
chromatin segmentation predictions among for 6 Tier 1 ENCODE
cell types [9]. We anticipate continually extending and improving
these annotations as dataset are made available from forthcoming
efforts such as The Roadmap Epigenomics Project [30].
Annotation file management, provenance, and
reproducibility
New genome annotation files can be quickly integrated into the
GEMINI framework, and since the loading step is easily
parallelized, the inclusion of new or updated annotation files in
the interest of empowering downstream analyses will not
substantially impact the time required to load GEMINI databases.
We maintain an internal record of the annotation files used by a
given GEMINI version and annotation files are stored on a public
server in the interest of transparency. In addition, in support of
research reproducibility, we document the provenance of each
annotation file as well as any post-processing that was required to
modify the files for use within GEMINI: https://github.com/
arq5x/gemini/tree/master/gemini/annotation_provenance.
The GEMINI database as a framework for data
exploration and tool development
Our primary motivation for directly integrating genetic variants
with genome annotations is to provide a flexible framework from
which to explore genetic variation for disease and population
genetic studies. Integrating these data in a single database provides
a standardized and consistent interface for disease genetics, data
querying and exploration, and new method development.
Moreover, our design allows us to adapt to evolving research
needs by quickly integrating new or improved genome annotations
in order to facilitate analysis and future method development.
To demonstrate the analytic utility of the database framework,
we provide several built-in tools for specific analyses (Fig. 2A,B).
The query tool is arguably the most powerful as it allows the
researcher to compose queries against the GEMINI database that
satisfy their exact research question using both pre-installed and
custom annotations. For example, Fig. 2A demonstrates a query
identifying novel, rare (,1% allele frequency), loss of function variants
that meet an autosomal recessive inheritance model and overlap
custom regions that are relevant to the researcher’s disease of interest.
As illustrated in Fig. 1D, sample genotype information (e.g., the
genotype, its ‘‘type’’ (heterozygote, homozygote, etc.), its phase,
and the observed sequencing depth) is stored as database columns
of compressed arrays, where each element in an array represents
the relevant genotype information for a single sample. While this
approach allows our database framework to easily scale to
thousands of samples without generating billions of database
rows, relational database systems do not inherently support queries
that directly access individual genotypes. Since interrogating
individual genotypes is crucial to studies of human disease, we
extended the SQL syntax in GEMINI to permit queries that place
conditions on individual genotypes (e.g., ‘‘SELECT gts.proband,
gts.mom, gts.dad’’) and filters (e.g., ‘‘gt_types.proband= =-
HOM_ALT’’) with a COLUMN.SAMPLE notation.
In addition, we provide other tools that address more intricate
research questions without requiring the researcher to write any
analysis code (Fig. 2B). These include tools for identifying de novo
mutations, as well as variants meeting both autosomal recessive
and autosomal dominant inheritance patterns in family-based
studies. In order to screen for these inheritance patterns, familial
relationships must be defined in an optional PED file (Fig. 1A),
which is subsequently stored in the samples table. We further
provide methods for prioritizing loss-of-function variants and
identifying putative compound heterozygous variants. By integrat-
ing pathway information from KEGG and protein interaction
data from HPRD, we provide tools for exploring the functional
pathways that variants affect, as well as networks of interacting
proteins with multiple functional variants in a given sample.
Importantly, we enable researchers to augment the GEMINI
database for their specific research needs. First, one may extend
the database with genome annotations that are relevant to their
own research. Secondly, researchers may create and integrate new
analysis tools that leverage the GEMINI framework via Python
scripts (Methods S1). This flexibility will allow developers to
extend GEMINI as new annotations and statistical methods (e.g.,
gene or region based burden tests) are developed (Fig. 2C).
Moreover, recognizing that many researchers are uncomfortable
with command-line data analysis tools, we have developed an inter-
face for accessing the above tools and their results via a web
browser. The browser interface integrates documentation of the
database schema and the available tools, and connects directly with
the IGV genome browser [31] allowing researchers to inspect the
primaryDNAsequencedataunderlyingindividualvariants(Fig.3).
Results
Database loading performance
Given the size and complexity of VCF files representing
variation among many samples, as well as the scale of genome
annotation files, the time and resources required to import a VCF
file and associated annotations into the GEMINI database were a
fundamental concern in the design of the system we have
developed. As such, loading a database can leverage multiple
processors in order to enable reasonable database loading times.
We support parallel processing on a single, multi-CPU machine
and on common computing cluster frameworks (e.g., Sun Grid
Engine, LSF, Torque): this inherent scalability will allow the
framework to keep pace with future genetic studies involving
thousands of samples. Parallel loading will enable the addition of
new annotations without fearing dramatic reductions in perfor-
mance. For example, using 4 processors, GEMINI required
84 minutes to load a VCF file representing 6.4 million variants
detected among a CEU trio (pedigree 1463; NA12877, NA12878,
NA12882) from the Illumina Platinum Genomes Project. Loading
a VCF file including the genotypes of all 1092 individuals from the
1000 Genomes Project (39.7 million variants; 1092 genotypes per
variant) required 28 hours using 30 processors.
Storage requirements
Since sample genotype information is stored as compressed
binary arrays in the variants table and many annotations are
stored more efficiently in a SQLite database than in a text-based
VCF format, the resulting GEMINI databases require substan-
tially less storage space than the original VCF files. For example, a
compressed version of the above 1000 Genomes VCF file requires
144 gigabytes after annotation with snpEff. In contrast, the corres-
Exploring Genetic Variation with GEMINI
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just over half the space (78 gigabytes). Moreover, the compression
ratio improves as the number of sample genotypes in the VCF file
increases.
Query performance
In principle, integrating genetic variation with genome anno-
tation facilitates complex analyses, yet this goal is only satisfied
through efficient database queries. Both GEMINI’s built-in
analysis tools and its ad hoc query interface are driven by a
common query interface to the underlying SQLite database.
Therefore, to assess the analytical performance of the underlying
database, we have measured the time required to conduct
representative ad hoc queries on GEMINI databases resulting
from the trio (‘‘GEMINI-trio’’) and 1092 sample (‘‘GEMINI-
1092’’) datasets above. As illustrated in Table 1, typical queries
complete in seconds or a few minutes, regardless of whether the
queries filter rows via a SQL ‘‘where’’ clause or via more
expensive genotype filters which require decompression of the
compressed sample genotype arrays. More importantly, query
runtimes scale sub-linearly with respect to both the number of
variants and the number of samples in the database, suggesting
that our framework is well suited to typical studies of human
disease. It is also important to emphasize that analytic perfor-
mance can be substantially improved by conducting several
queries concurrently on the same database.
Availability and Future Directions
We have developed a flexible new analysis framework that
scales to the demands of both family-based disease studies and
large-scale investigations involving thousands of individuals. By
Figure 3. The GEMINI browser interface. In an effort to enable collaborative research and to support users who are less comfortable working on
a UNIX command line, we also provide a web browser interface to GEMINI databases. This figure depicts the browser interface to the GEMINI query
module; and, as illustrated in the navigation bar, interfaces also exist to other built-in analysis tools (e.g., for finding de novo mutations) and to the
GEMINI documentation. (A) The browser interface to the query module allows users to run custom analysis queries in order to identify variants of
interest. (B) Users may also enforce ‘‘genotype filters’’ that restrict the returned variants to those that meet specific genotype conditions or
inheritance patterns. (C) Additional options are provided allowing the user to 1) add column headers describing the name of each column selected,
2) to create automatic links to the Integrative Genomics Viewer (IGV) from the reported variants, thus facilitating data exploration and validation, and
3) to report results to either the web browser or to a text file for downstream analysis.
doi:10.1371/journal.pcbi.1003153.g003
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diverse and continually expanding set of genome annotations,
GEMINI provides a uniquely powerful resource for exploring and
interpreting both coding and non-coding genetic variation.
Elucidating the genetic variants that underlie both unsolved single
gene disorders and complex disease phenotypes requires the
integration of a broad range of genome and disease annotations.
Indeed a recent review of the challenges facing the interpretation
of cancer genomes argues that a more detailed understanding of
cancer etiology will require the integration of diverse information
including pathway annotations, chromatin modifications, DNA
methylation, and expression data [32]. GEMINI enables the
integration of many large and heterogeneous genome annotations
and as such, it provides a powerful tool to address the analytical
demands of complex disease research. Therefore, we anticipate
that the GEMINI framework will facilitate discovery in a broad
range of research into the genetic basis of human diseases,
including studies of individual genomes, unsolved Mendelian
disorders, explorations of rare variants in large pedigrees, and
genome-wide case-control studies. Moreover, we expect that
GEMINI’s portability and inherent reproducibility will allow other
developers to extend the framework to create new data exploration
and visualizing tools and develop novel approaches to prioritizing
genetic variation in diverse contexts.
Given the clear necessity of such tools for advancing medicine
in the genomic age, it is not surprising that several new
commercial software packages have been developed in the last
two years. Our goal is to provide a scalable, open-source
medical genomics tool enabling other researchers to easily
integrate new methods and genome annotations for the benefit
of the human genomics research community. In future work we
will continue to increase the performance of the software,
expand the set of integrated genome annotations, and enhance
the Python programming interface in order to facilitate tool and
new method development. In addition, while we anticipate that
the existing SQLite-based framework will be capable of handling
tens of thousands of individuals, we will explore the alternate use
of more scalable and/or distributed database systems for larger
studies.
GEMINI is a freely available, open-source software package.
The source code is maintained and available at: https://github.
com/arq5x/gemini. Extensive documentation is available at
http://gemini.readthedocs.org/ and as Text S1.T h es o f t w a r e
is primarily implemented in Python while aspects crucial to
performance are implemented in C and C++. Instructions and
data files for recreating the GEMINI databases representing the
Platinum Trio and the 1092 individuals from the 1000 Genomes
project are available at: http://quinlanlab.cs.virginia.edu/.
Supporting Information
Methods S1 The GEMINI Python programming inter-
face.
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Protocol S1 GEMINI source code, documentation, and
unit test files.
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